GTx (United States)
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator and selective androgen receptor modulator classes. Its drugs in development included enobosarm and GTx-758. The company was founded in Memphis in 1997 by Mitch Steiner and Marc S. Hanover. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GTx (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
23%
Total
Publications
26K
Total Open
Publications
6K
Total
Citations
1M
Open Access
Percentage
23%
Total
Publications
26K
Total Open
Publications
6K
Total
Citations
1M
Breakdown
Publisher Open
12%
Both
5%
Other Platform Open
9%
Closed
74%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
1.8K
Hybrid 26%
1.2K
No Guarantees 35%
1.7K
Other Platform Open
Domain 61%
2.3K
Institution 32%
1.2K
Other Internet 14%
536
Public 2%
63
Preprint 0%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.3K |
DOI | Other Internet | 438 |
DANS - Data Archiving and Networked Services | Institution | 162 |
Unknown Repository | Other Internet | 102 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 82 |
Europe PMC | Domain | 60 |
Academy of Humanities and Economics in Lodz - Homo Politicus | Institution | 57 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 50 |
University of Zurich - Zurich Open Repository and Archive | Institution | 47 |
Zenodo | Public | 40 |